Integer Holdings Co. (NYSE:ITGR - Get Free Report) VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the sale, the vice president now owns 2,813 shares of the company's stock, valued at $320,682. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Integer Trading Up 0.1 %
ITGR stock traded up $0.14 during midday trading on Thursday, reaching $109.92. 237,040 shares of the company's stock traded hands, compared to its average volume of 344,416. The company has a market capitalization of $3.68 billion, a P/E ratio of 37.98, a PEG ratio of 1.65 and a beta of 1.12. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $123.99. The business has a 50-day moving average price of $113.86 and a two-hundred day moving average price of $100.67.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.02. The firm had revenue of $414.80 million for the quarter, compared to analysts' expectations of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. Integer's revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.87 earnings per share. Equities research analysts forecast that Integer Holdings Co. will post 5.27 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on ITGR. Bank of America upgraded shares of Integer from a "neutral" rating to a "buy" rating and boosted their target price for the company from $105.00 to $135.00 in a report on Monday, April 15th. CL King began coverage on shares of Integer in a report on Thursday, March 14th. They issued a "buy" rating and a $137.00 target price for the company. Benchmark restated a "buy" rating and issued a $130.00 target price on shares of Integer in a report on Friday, April 26th. Finally, KeyCorp boosted their target price on shares of Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a report on Tuesday, April 9th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Integer currently has a consensus rating of "Moderate Buy" and a consensus price target of $120.50.
Get Our Latest Research Report on Integer
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. lifted its position in shares of Integer by 497.0% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider's stock worth $42,065,000 after purchasing an additional 446,508 shares in the last quarter. Public Employees Retirement Association of Colorado raised its holdings in Integer by 3,260.1% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider's stock valued at $28,281,000 after acquiring an additional 276,944 shares in the last quarter. Norges Bank acquired a new stake in Integer in the fourth quarter valued at $18,697,000. Victory Capital Management Inc. raised its holdings in Integer by 8.9% in the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider's stock valued at $128,041,000 after acquiring an additional 133,898 shares in the last quarter. Finally, FMR LLC raised its holdings in Integer by 12.8% in the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider's stock valued at $67,759,000 after acquiring an additional 97,851 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.
About Integer
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
